These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29191358)

  • 1. [Stereotactic body radiation therapy for oligometastatic prostate cancer].
    Bibault JE
    Bull Cancer; 2018 Jan; 105(1):120-125. PubMed ID: 29191358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Prostate Cancer.
    Zhang B; Leech M
    Anticancer Res; 2020 May; 40(5):2419-2428. PubMed ID: 32366385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
    Niazi T; Elakshar S; Stroian G
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.
    Patel PH; Chaw CL; Tree AC; Sharabiani M; van As NJ
    World J Urol; 2019 Dec; 37(12):2615-2621. PubMed ID: 31346760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of radiotherapy to the primary tumor and metastases in patients with oligometastatic prostate cancer].
    Le Roy T; Baron D; Vandendorpe B; Bataille B; Hannoun-Levi JM; Blanchard P; Lartigau E; Latorzeff I; Pasquier D
    Cancer Radiother; 2021 Oct; 25(6-7):526-532. PubMed ID: 34400086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Huynh MA; Tang C; Siva S; Berlin A; Hannan R; Warner A; Koontz B; De Meeleer G; Palma D; Ost P; Tran PT
    Eur Urol Oncol; 2023 Feb; 6(1):28-38. PubMed ID: 36283936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Muldermans JL; Romak LB; Kwon ED; Park SS; Olivier KR
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):696-702. PubMed ID: 27131082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.
    Connor MJ; Smith A; Miah S; Shah TT; Winkler M; Khoo V; Ahmed HU
    Eur Urol Oncol; 2020 Oct; 3(5):582-593. PubMed ID: 32891600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.
    Ost P; Jereczek-Fossa BA; Van As N; Zilli T; Tree A; Henderson D; Orecchia R; Casamassima F; Surgo A; Miralbell R; De Meerleer G
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e115-20. PubMed ID: 27133946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience.
    Ponti E; Ingrosso G; Carosi A; Di Murro L; Lancia A; Pietrasanta F; Santoni R
    Clin Genitourin Cancer; 2015 Aug; 13(4):e279-e284. PubMed ID: 25604915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
    Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
    BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of stereotactic body radiation therapy for oligometastatic recurrent prostate cancer: A systematic review.
    Vilela RA; Navarro NF; Faria ET; Ferreira EB; Ruzza RZ; Gadia R; Guerra ENS; Reis PEDD
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):692-706. PubMed ID: 29808571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.
    Pasqualetti F; Panichi M; Sainato A; Matteucci F; Galli L; Cocuzza P; Ferrazza P; Coraggio G; Pasqualetti G; Derosa L; Sollini M; Mannelli L; Ortori S; Monzani F; Ricci S; Greco C; Fabrini MG; Erba PA
    Radiat Oncol; 2016 Jan; 11():9. PubMed ID: 26796633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
    Bouman-Wammes EW; van Dodewaard-De Jong JM; Dahele M; Cysouw MCF; Hoekstra OS; van Moorselaar RJA; Piet MAH; Verberne HJ; Bins AD; Verheul HMW; Slotman BJ; Oprea-Lager DE; Van den Eertwegh AJM
    Clin Genitourin Cancer; 2017 Oct; 15(5):e773-e782. PubMed ID: 28462855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer.
    Pasqualetti F; Panichi M; Sainato A; Baldaccini D; Cocuzza P; Gonnelli A; Montrone S; Molinari A; Barbiero S; Bruschi A; Notini E; Ursino S; Mazzotti V; Morganti R; Coraggio G; Cantarella M; Erba PA; Paiar F
    Anticancer Res; 2018 May; 38(5):3119-3122. PubMed ID: 29715150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.
    Phillips R; Shi WY; Deek M; Radwan N; Lim SJ; Antonarakis ES; Rowe SP; Ross AE; Gorin MA; Deville C; Greco SC; Wang H; Denmeade SR; Paller CJ; Dipasquale S; DeWeese TL; Song DY; Wang H; Carducci MA; Pienta KJ; Pomper MG; Dicker AP; Eisenberger MA; Alizadeh AA; Diehn M; Tran PT
    JAMA Oncol; 2020 May; 6(5):650-659. PubMed ID: 32215577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].
    Le Fèvre C; Antoni D; Thiéry A; Keller A; Truntzer P; Vigneron C; Clavier JB; Guihard S; Pop M; Schumacher C; Salze P; Noël G
    Cancer Radiother; 2018 Apr; 22(2):148-162. PubMed ID: 29602695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
    Leduc C; Antoni D; Quoix É; Noël G
    Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.